Journal article icon

Journal article

Immunotherapy-resistant neuropathic pain and fatigue predict quality-of-life in contactin-associated protein-like 2 antibody disease

Abstract:
The long-term clinical outcomes and associated prognostic factors in contactin-associated protein-like 2 (CASPR2)-antibody diseases are unknown. A total of 75 participants with CASPR2 antibodies were longitudinally assessed for disability, quality-of-life, and chronic pain. Although most symptoms improved within 6 months of treatment, neuropathic pain and fatigue were the most immunotherapy refractory, and persisted for up to 6 years. Furthermore, these two factors—but not CASPR2 antibody levels or subclasses—independently predicted worse disability and quality-of-life at 24 months. Quality-of-life varied widely for any given modified Rankin Scale score, indicating a divergence between patient and clinician assessed outcomes. Further work should study the relative importance of these measures, and the immunopathogenesis underlying intractable symptoms. ANN NEUROL 2025
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Publisher copy:
10.1002/ana.27177

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Clinical Neurosciences
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Clinical Neurosciences
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Clinical Neurosciences
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Clinical Neurosciences
Role:
Author


More from this funder
Funder identifier:
https://ror.org/03wnrjx87
Grant:
IES\R3\213098
More from this funder
Funder identifier:
https://ror.org/029chgv08
Grant:
104079/Z/14/Z
102176/Z/13/Z
More from this funder
Funder identifier:
https://ror.org/03x94j517
Grant:
MR/V007173/1
MR/X022013/1
More from this funder
Funder identifier:
https://ror.org/0187kwz08
Grant:
BRCRCF19-04


Publisher:
Wiley
Journal:
Annals of Neurology More from this journal
Volume:
97
Issue:
3
Pages:
521-528
Publication date:
2025-01-18
Acceptance date:
2024-12-20
DOI:
EISSN:
1531-8249
ISSN:
0364-5134


Language:
English
Pubs id:
2072296
Local pid:
pubs:2072296
Deposit date:
2024-12-24

Terms of use



Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP